ZA773927B - 5-m-tolyloxyuracil,anti-ulcer agent - Google Patents

5-m-tolyloxyuracil,anti-ulcer agent

Info

Publication number
ZA773927B
ZA773927B ZA00773927A ZA773927A ZA773927B ZA 773927 B ZA773927 B ZA 773927B ZA 00773927 A ZA00773927 A ZA 00773927A ZA 773927 A ZA773927 A ZA 773927A ZA 773927 B ZA773927 B ZA 773927B
Authority
ZA
South Africa
Prior art keywords
tolyloxyuracil
ulcer agent
ulcer
agent
Prior art date
Application number
ZA00773927A
Other languages
English (en)
Inventor
C Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA773927B publication Critical patent/ZA773927B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
ZA00773927A 1976-07-16 1977-06-29 5-m-tolyloxyuracil,anti-ulcer agent ZA773927B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
ZA773927B true ZA773927B (en) 1978-05-30

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00773927A ZA773927B (en) 1976-07-16 1977-06-29 5-m-tolyloxyuracil,anti-ulcer agent

Country Status (29)

Country Link
US (1) US4080454A (da)
JP (1) JPS5337673A (da)
AR (1) AR213652A1 (da)
AT (1) AT351561B (da)
BE (1) BE856710A (da)
CA (1) CA1061788A (da)
CH (1) CH622512A5 (da)
CS (1) CS212264B2 (da)
DD (1) DD131556A5 (da)
DE (1) DE2731736A1 (da)
DK (1) DK139029B (da)
EG (1) EG12762A (da)
ES (1) ES460686A1 (da)
FI (1) FI772183A (da)
FR (1) FR2358399A1 (da)
GB (1) GB1542178A (da)
GR (1) GR68686B (da)
HU (1) HU177713B (da)
IL (1) IL52409A (da)
LU (1) LU77764A1 (da)
NL (1) NL7707729A (da)
NO (1) NO772489L (da)
PH (1) PH13190A (da)
PL (1) PL103783B1 (da)
PT (1) PT66808B (da)
SE (1) SE421125B (da)
SU (1) SU673169A3 (da)
YU (1) YU171677A (da)
ZA (1) ZA773927B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
JPS5822406U (ja) * 1981-08-04 1983-02-12 トキコ株式会社 消音器
NZ565955A (en) 2005-08-22 2011-08-26 Melior Pharmaceuticals I Inc Methods and formulations for modulating lyn kinase activity and treating related disorders
KR20100014480A (ko) * 2007-02-20 2010-02-10 멜리어 파마슈티칼스 아이, 인코포레이티드 Ｌｙｎ 키나제 활성제의 확인 방법
NZ579288A (en) * 2007-07-23 2012-06-29 Melior Discovery Inc Methods of activating irs-1 and akt
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
NZ758966A (en) 2017-04-10 2024-08-30 Board Of Supervisors Of Louisiana State Univ And Agricultural And Mechanical College Treatment of adipocytes
AU2019223911A1 (en) 2018-02-21 2020-07-23 Melior Pharmaceuticals I, Inc. Treatment of liver diseases

Also Published As

Publication number Publication date
SE7707471L (sv) 1978-01-17
AU2663877A (en) 1978-05-18
DD131556A5 (de) 1978-07-05
SE421125B (sv) 1981-11-30
IL52409A0 (en) 1977-08-31
FR2358399A1 (fr) 1978-02-10
FI772183A (da) 1978-01-17
YU171677A (en) 1982-06-30
PH13190A (en) 1980-01-16
NO772489L (no) 1978-01-17
JPS5337673A (en) 1978-04-06
PL103783B1 (pl) 1979-07-31
BE856710A (fr) 1978-01-11
GR68686B (da) 1982-02-01
PL199633A1 (pl) 1978-04-10
ES460686A1 (es) 1978-12-01
CH622512A5 (da) 1981-04-15
PT66808A (en) 1977-08-01
SU673169A3 (ru) 1979-07-05
IL52409A (en) 1979-11-30
FR2358399B1 (da) 1980-10-17
AR213652A1 (es) 1979-02-28
DE2731736A1 (de) 1978-01-26
HU177713B (en) 1981-12-28
GB1542178A (en) 1979-03-14
EG12762A (en) 1979-12-31
US4080454A (en) 1978-03-21
DK318177A (da) 1978-01-17
DK139029C (da) 1979-05-07
NL7707729A (nl) 1978-01-18
AT351561B (de) 1979-08-10
CA1061788A (en) 1979-09-04
LU77764A1 (da) 1978-02-02
ATA509277A (de) 1979-01-15
DK139029B (da) 1978-12-04
CS212264B2 (en) 1982-03-26
JPS5512017B2 (da) 1980-03-29
PT66808B (en) 1978-12-21

Similar Documents

Publication Publication Date Title
MY8300172A (en) 2-piperazinyl-6,7-dimethoxyquinazolines
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
GB1524917A (en) Gona-1,9(10)-dienes
NZ183143A (en) 2-aminoakyl-1,2-benzisothiazol 3-anes
ZA773927B (en) 5-m-tolyloxyuracil,anti-ulcer agent
PH17398A (en) 1,5-disubstituted-2-pyrrolidones
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
IL52424A0 (en) 2,6-methano-2h-1-benzoxocins
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
JPS52117436A (en) Antiicoccidium agent
AU2468877A (en) 1,4 -dicyanobytene
PH15728A (en) 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
GB1537635A (en) 15,16-dihydroxyprostaglandins
JPS52114025A (en) Antiitumor agent
GB1554049A (en) 2-decarboxy-2-hydroxymethyl-13,14-didehydroprostaglandins
GB1547729A (en) 1-phenyl-4-acetoxy-1,2-dihydroquinolin-2-ones
IL53527A (en) N1-chloro-3,5-dinitrosulfanilamides
NZ184082A (en) 1-benzothiazol-2yl-1,3-imidazolidin-2-ones
AU3191777A (en) 1,4-oxathianes
IL52893A0 (en) Antimalignant agent
GB1554045A (en) 13,14-didehydroprostaglandins
ZA774088B (en) 2,5-dichloro-4-bromphenylazo-4-chloro-phenyl-sulphide
AU492806B2 (en) 5-m-TOLYLOXYURACIL, ANTIULCER AGENT
EG12897A (en) N,n,methylebebis-co,o-diaryl-n-phosphonomethylglycinonitrilles
IE812329L (en) N, n-bisphenylethylamines